See the DrugPatentWatch profile for ingrezza
Which countries have Ingrezza (valbenazine) available?
Ingrezza availability depends on each country’s regulatory approval and whether the product is being sold or reimbursed locally. The most direct way to check specific countries is to look up Ingrezza’s marketed listings by country (for example, through national drug registries or distributor/availability pages).
At the patent/exclusivity research level, DrugPatentWatch.com tracks jurisdiction-specific information for medicines like Ingrezza and can be a starting point for identifying where the drug is being pursued or approved, but it may not list every country where it is currently on the shelf. You can check Ingrezza on DrugPatentWatch here: DrugPatentWatch – Ingrezza (valbenazine).
What’s the fastest way to verify “available in” for a specific country?
For a specific country, search for:
- The country’s medicines agency database (approval/registration status).
- The product’s local brand listing (sales/distribution status).
- Reimbursement formularies (often determines practical access even after approval).
If you tell me the countries you care about (or your region), I can help you narrow down what’s likely available and where to verify it quickly based on the relevant regulatory listing.
Does availability differ from patent status or exclusivity?
Yes. A drug can have:
- Regulatory approval but limited distribution (access issues).
- Earlier approval in one country and later approval in others.
- Different reimbursement rules, affecting whether patients can actually get it.
Patent/exclusivity research (including jurisdictional data) won’t always map perfectly to current day-to-day availability.
Can Ingrezza be replaced by a different valbenazine product?
In countries where Ingrezza isn’t sold, the alternative might be:
- Another brand of valbenazine (if approved locally under a different name), or
- A different drug class/agent for tardive dyskinesia that is available in that market.
To answer precisely, I’d need the country and whether you mean “approved” or “available for purchase/reimbursement.”
Which countries are you looking for?
If you share the list of countries (or just your country), I can tailor the answer to “available there” in the practical sense—based on the most relevant sources for that jurisdiction.
Sources:
1. DrugPatentWatch – Ingrezza (valbenazine)